-
Signature
-
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Jeffrey A. Davis
-
Stock symbol
-
LH
-
Transactions as of
-
Feb 6, 2025
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
2/10/2025, 08:46 AM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
LH |
Common Stock |
Options Exercise |
|
+944 |
+26.08% |
|
4.56K |
Feb 6, 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
LH |
Restricted Stock Unit |
Options Exercise |
$0 |
-944 |
-100% |
$0.00 |
0 |
Feb 6, 2025 |
Common Stock |
944 |
|
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
On May 17, 2024, LHI became the successor of Laboratory Corporation of America Holdings ("LCAH") pursuant to LCAH's reorganization into a new holding company structure (the "Reorganization"). The Reorganization resulted in LHI becoming a parent holding company of LCAH but did not alter the proportionate interests of LCAH security holders.